Linical Co (2183.T) Stock Price

Linical Co Price

JPX·CLOSED
197.00
​
Market closed

Over the last 19 years Linical Co grew revenue by 15.0% annually, reaching 8.67 B JPY. Earnings per share have grown at 6.6% per year over the last 17 years. For Linical Co, the net margin of -38.4% is down versus 6.8% a few years ago. At today's price the dividend yield works out to roughly 16.24%. The payout ratio is around 57% of earnings. The dividend has grown at 10.9% per year over the past 17 years.

Linical Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Linical Co business model & stock analysis

Linical Co., Ltd. generates revenue through two distinct business segments, the CRO segment and the Pharmaceutical Sales Support segment. The CRO segment provides contract monitoring, quality management, and consulting services specifically for phase II and phase III in drug development processes. These services are delivered to pharmaceutical companies as part of pharmaceutical contract research projects. The Pharmaceutical Sales Support segment focuses on the downstream market by providing pharmaceutical sales support for medical institutions. The company operates these businesses from its headquarters in Osaka, Osaka-Fu, leveraging its workforce of 759 full-time employees to deliver these specialized services.

Frequently asked questions about Linical Co

7 analysts currently rate the Linical Co stock: 0 recommend buying, 3 holding and 4 selling.

Converted at the current exchange rate, the Linical Co share trades at 1.12 EUR (197.00 JPY).

The Linical Co share (2183.T) is listed on 1 stock exchanges, including: Tokio (JPX) (2183.T).

The revenue of Linical Co is 8.67 B JPY. This figure is based on current financial data and reflects the company's business performance.

The profit of Linical Co is -3.33 B JPY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Linical Co is currently -1.34. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Linical Co stock.

The price-to-sales ratio (P/S) of Linical Co is currently 0.51. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Linical Co stock.

The Eulerpool Quality Score for Linical Co is 2/10.

The ISIN of Linical Co is JP3974530002. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Linical Co is 2183.T. The ticker symbol is used to trade Linical Co shares on the stock exchange.

Fair ValueTerminal
167.45 JPY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Life Sciences Tools & Services
Number of shares
Employees
Revenue per Employee
11.42 M JPY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
JPY
Initial public offering
Oct 27, 2008
ISIN
JP3974530002
Cusip
J3903A109
Market capitalization
4.87 B JPYMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2027
6.63
P/S
P/Se
0.34
EV/EBIT
—
P/B Ratio
1.23
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-53.47 %
Dividend
Dividend yield
16.24 %
Est. Dividend Yield
16.24 %
Payout Ratio
57.21 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
17 years
Dividend not reduced since
17 years
Dividend increased since
2 years
Dividend withholding tax
15.32 %
Last updated Nov 9, 2026, 3:45 AM

Linical Co Peer Group

Linical Co Ticker

JPX · 2183.T

Linical Co FIGI

2183:JP · BBG000J4YMW92183:JT · BBG000J4YN112183:JJ · BBG000J4YVW92183:JE · BBG000J4YY622183:JI · BBG000J4YYK62183:JU · BBG002QKH3072183:JW · BBG00875K3862183JPY:X2 · BBG00K6FNK142183JPY:XB · BBG00K6FNK232183JPY:XH · BBG00K6FNK412183JPY:XF · BBG00K6FNK692183JPY:XE · BBG00K6FNK87

All fundamentals and in-depth analysis of Linical Co

Our stock analysis for Linical Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Linical Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.